Hot Natural Products & Bioactive Compounds
BioCrick offers high-purity natural products and bioactive compounds for scientific research. Our natural product collection includes compounds derived from plants, microorganisms and other biological sources and is widely used in pharmacological, biochemical and drug discovery research.
Natural products remain an important source of bioactive molecules and drug leads. BioCrick provides researchers with high-quality natural product compounds together with catalog numbers, product information and biological activity data.
Hot Products from BioCrick
Showing 1689 - 1696 of 9359 hot products
| Catalog No. | Product Name |
|---|---|
| BCC6091 | GPi 688 |
|
Allosteric glycogen phosphorylase inhibitor; acts at the indole site of glycogen phosphorylase. Inhibits glucagon-mediated hyperglycemia in vivo in the rat.
|
|
| BCC6092 | AR-C 102222 |
|
Inducible nitric oxide synthase (iNOS) inhibitor; selective for iNOS over eNOS (IC<sub>50</sub> values are 0.037 and >100 <span class='symbol'>μ</span>M for iNOS and eNOS respectively). Exhibits antinociceptive and anti-inflammatory activity in rodent pain models.
|
|
| BCC6093 | Nalmefene - d3 |
|
Deuterated nalmefene.
|
|
| BCC6094 | MEN 11270 |
|
Peptide antagonist of the B<sub>2</sub> bradykinin receptor (pK<sub>i</sub> = 10.3); conformationally constrained cyclized analog of HOE 140. Blocks hypotension and bronchoconstriction <em>in vivo</em>. Displays selectivity for B<sub>2</sub> over 29 other receptors and ion channels (pIC<sub>50</sub> < 5.5).
|
|
| BCC6095 | PSB 0739 |
|
Highly potent P2Y<sub>12</sub> receptor antagonist (K<sub>i</sub> = 24.9 nM). Unlike clopidogrel, does not require bioactivation.
|
|
| BCC6096 | Alda 1 |
|
Activator of aldehyde dehydrogenase 2 (ALDH2). Increases activity of wild-type ALDH2*1 and variant ALDH2*2 (by ~2-fold and 11-fold respectively). Capable of partly restoring mutant ALDH2*2 activity; protective against cardiac ischemia.
|
|
| BCC6097 | EC 23 |
|
Photostable synthetic retinoid; analog of ATRA. Displays similar activity to ATRA when tested on the embryonal carcinoma stem cell model TERA2.cl.SP12. Potently induces neural differentiation in human pluripotent embryonic stem cells.
|
|
| BCC6098 | SR 140333 |
|
Potent NK<sub>1</sub> receptor antagonist (K<sub>i</sub> = 0.74 nM. IC<sub>50</sub> = 1.6 nM). Inhibits substance P</a>-invoked calcium mobilization and outward current (IC<sub>50</sub> = 1.3 nM); blocks NK<sub>1</sub>-mediated nitric oxide-dependent vasodilation <em>in vivo</em>.
|
|